TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Deadline Alert: MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Glancy Prongay & Murray Llp
Deadline Alert: MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

MoonLake Immunotherapeutics faces potential securities fraud lawsuit after announcing disappointing Phase 3 results for its drug candidate sonelokimab, which failed to match competitor's efficacy and caused significant stock price drop.

Insights
ZIONP   negative

Announced a significant $50 million loan charge-off, experienced substantial stock price decline, and is facing potential legal action due to alleged misrepresentations and contractual defaults


MLTX   negative

Stock price dropped 89.9% after revealing Phase 3 trial failure, with allegations of misleading investors about drug candidate's potential advantages